Rucha Patil: Scaling POC Diagnostics for Haemophilia A and VWD Across India
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared a post on LinkedIn:
“Two days of meaningful discussions, collaboration and a shared mission to strengthen haemophilia and haemoglobinopathies care in India.
15-16 October 2026 | Delhi
Landed in Delhi to pleasant weather and headed straight to the HFI office, where it was a pleasure meeting Habib Bennaceur, NNHF Council President, and Alec van Gelder, Vice President, Corporate Affairs, Novo Nordisk Haemophilia & Haemoglobinopathies Foundation.
We had insightful discussions on haemophilia treatment and diagnostics in India. I was particularly happy to share excellent progress made in the pilot implementation of ICMR-developed point-of-care (POC) kits for haemophilia A and von Willebrand disease (VWD) in two states, with the valuable support of NNHF.
The informal dinner discussions were equally important, highlighting both India’s strengths and the gaps that remain in haemophilia and haemoglobinopathies care for which we remain determined to address them through collaboration, innovation and focused action.
Day 2 was dedicated to a mission-mode meeting organised by Shikha Jha, along with Shobha Tuli ma’am, Dr Heena Tabassum, Anupam Dutta, Dr. Lakhan Poshniwal, Premroop Alva, Dr. Suman Jain
Dr. J S Arora, Sh. Gautam Dongre. The meeting focused on reviewing progress, identifying priorities and charting the way forward.
Always a pleasure to be part of fruitful discussions that translate shared vision into meaningful action. The goal remains clear: bridging gaps and ensuring better access to diagnosis and treatment for people living with bleeding disorders across India.”

Stay updated with Hemostasis Today.
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question
-
Oct 20, 2026, 04:04Sadia Kamal: Honored to Receive the Outstanding Abstract Award at the 20th Midwest Platelet Conference
-
Oct 20, 2026, 04:03Yu-Hsuan Chen: One Antibody, Two Diseases from FcRn Biology to Clinical Translation
-
Oct 20, 2026, 03:49Domenico Simone Castiello: Rethinking Prolonged DAPT in Multivessel PCI – Insights from the DAPT-MVD Trial
-
Oct 20, 2026, 03:31Zena Vexler: Targeting Neutrophil Elastase and NETosis to Mitigate Infection-Triggered Childhood Stroke
-
Oct 20, 2026, 03:24Chaza Alaji: Diagnosing Protein C and Protein S Deficiency
-
Oct 20, 2026, 03:24Mou Nandi: How Maternal Health During Pregnancy May Shape Infant Development